Venture Debt Leader Hercules Technology Growth Capital Continues to Expand Team with Three New Senior Hires
New Hires Position Company for Anticipated Growth Going into 2014
Palo Alto Office Expands its Technology and Life Sciences Teams
Boston Office Enhances Team by Adding a Portfolio Credit Manager
PALO ALTO, Calif.--(BUSINESS WIRE)--
Hercules Technology Growth Capital, Inc. (NYSE: HTGC), the leading
specialty finance company focused on providing senior secured loans to
venture capital-backed companies in technology-related markets,
including technology, biotechnology, life science, and energy and
renewables technology industries, at all stages of development, today
announced that it has hired three new senior professionals to its
origination platform and credit teams.
"As we expect the demand for venture debt to expand, we continue to add
thoughtful, high-caliber investment professionals to our team who
understand the specific sectors we focus on and the businesses of the
companies we work with on a daily basis," said Manuel A. Henriquez,
co-founder, chairman and chief executive officer of Hercules. "We
believe finding the right people is equally as important as identifying
the right companies to invest in. This remains an important tenet of
ours as we continue deploying our available liquidity into new,
interest-earning assets and position Hercules for anticipated growth as
we move into 2014."
The following executives have joined the firm:
Tony Pandjiris, Managing Director, Technology Group, Palo Alto,
CA — Pandjiris, a former investment banker, has more than 15
years of experience in identifying and working with promising,
emerging technology companies, corporate strategy, and transaction
leadership. Prior to joining Hercules, Pandjiris was a vice president
with Morgan Stanley where he originated and executed scores of
corporate finance and M&A transactions. Prior to that, Pandjiris was
an investment banker with UBS where he executed investment banking
transactions for companies in the electronics, hardware, software, and
semiconductor industries. Earlier in his career, Pandjiris was an
associate with Comdisco Ventures where he was part of a team that
managed high-tech portfolio structuring debt and equity investments to
various venture capital backed technology and life sciences companies.
Christopher Parham, MD & PhD, Principal, Life Science
Group, Palo Alto, CA — Parham has over 15 years of experience in
clinical medicine. As a board-certified medical doctor in radiology,
Parham has extensive practical and operational healthcare experience
in both hospital and outpatient settings. In addition to his medical
experience, Parham is a biomedical engineer specializing in medical
imaging hardware design and development, and has three device patents.
Previously, he co-founded a medical device company called NextRay to
further develop Diffraction Enhanced Imaging technology.
Mark Roesler, Portfolio Credit Manager, Boston, MA — Roesler is
a senior risk and credit professional with 25 years of experience
across a variety of industry segments and lending platforms. Prior to
joining Hercules, Roesler served as a senior credit officer with
CapitalSource Bank. Roesler also held senior positions with GE Capital
Healthcare Financial Services, GE Capital Vendor Financial Services,
and Firestone Financial.
About Hercules Technology Growth Capital, Inc.:
Hercules Technology Growth Capital, Inc. (NYSE: HTGC) ("Hercules") is
the leading specialty finance company focused on providing senior
secured loans to venture capital-backed companies in technology-related
markets, including technology, biotechnology, life science and energy
and renewables technology industries, at all stages of development.
Since inception (December 2003), Hercules has committed more than $3.9
billion to over 250 companies and is the lender of choice for
entrepreneurs and venture capital firms seeking growth capital financing.
Hercules' common stock trades on the New York Stock Exchange (NYSE)
under the ticker symbol "HTGC."
In addition, Hercules has two outstanding bond issuances of 7.00% Senior
Notes due 2019—the April 2019 Notes and September 2019 Notes—which trade
on the NYSE under the symbols "HTGZ" and "HTGY," respectively.
Companies interested in learning more about financing opportunities
should contact firstname.lastname@example.org, or call
Statements in this press release may constitute forward-looking
statements for purposes of the safe harbor protection under applicable
securities laws. Forward-looking statements can be identified by
terminology such as "anticipate," "believe," "could," "estimate,"
"expect," "intend," "is planned," "may," "should," "will," "will
enable," "would be expected," "look forward," "may provide," "would" or
similar terms, variations of such terms or the negative of those terms.
Such forward-looking statements involve known and unknown risks,
uncertainties and other factors including, without limitation, those
risks, uncertainties and factors referred to in the "Risk Factors"
section of the Hercules Annual Report on Form 10-K for the year ended
December 31, 2012, as well as the other documents and reports filed by
Hercules with the Securities Exchange Commission. As a result of such
risks, uncertainties and factors, actual results may differ materially
from any future results, performance or achievements discussed in or
implied by the forward-looking statements contained herein. Hercules is
providing the information in this press release as of this date and
assumes no obligations to update the information included in this press
release or revise any forward-looking statements, whether as a result of
new information, future events or otherwise.
Hercules Technology Growth Capital, Inc.
Muirfield Partners HT-HN
Ed Keaney, 415-445-3236
Source: Hercules Technology Growth Capital, Inc.
News Provided by Acquire Media
Close window | Back to top